Robinson v. Union Carbide Corporation ( 2019 )


Menu:
  •        IN THE SUPERIOR COURT OF THE STATE OF DELAWARE
    MARIANNE ROBINSON, individually :
    and as Personal Representative for the :       C.A. No. N17C-06-143 (ASB)
    Estate of JACK B. ROBINSON,            :
    Deceased,                              :
    :
    Plaintiff,           :
    :
    v.                      :
    :
    UNION CARBIDE CORPORATION, :
    :
    Defendant.             :
    OPINION
    Submitted: May 29, 2019
    Decided: August 15, 2019
    Patrick J. Smith, Esquire, BALICK & BALICK, LLC., Wilmington, Delaware, for
    the Plaintiff.
    Joseph S. Naylor, Esquire, SWARTZ CAMPBELL, LLC, Wilmington, Delaware,
    for the Defendant.
    Clark, J.
    Defendant Union Carbide Corporation (“UCC”) moves for summary
    judgment against Plaintiff Marianne Robinson (“Ms. Robinson”). This suit involves
    UCC’s sale of its bulk asbestos product, Calidria, to an intermediary, Georgia-
    Pacific.    For many years, Georgia-Pacific included UCC’s Calidria in joint
    compounds that it sold to consumers. Ms. Robinson alleges that her husband used
    these compounds. He was later diagnosed with lung cancer in July 2016, and has
    since passed away.
    Here, Ms. Robinson sues UCC in her personal capacity and as Mr. Robinson’s
    survivor. First, she sues UCC for its alleged failure to warn Mr. Robinson about
    Calidria’s hazards. She also sues UCC pursuant to an Ohio statute that provides for
    strict liability for defectively designed or formulated products.
    Based upon the facts of record, there are no genuine issues of material fact
    regarding Georgia-Pacific’s status as a sophisticated intermediary. Nor are there
    genuine issues of material fact regarding the sufficiency of UCC’s warnings to
    Georgia-Pacific, or UCC’s reasonable reliance upon Georgia-Pacific to warn Mr.
    Robinson. Accordingly, UCC had no duty to warn Mr. Robinson about the dangers
    of UCC’s bulk asbestos product.
    With regard to her strict liability claim, raw products such as Calidria
    potentially fit within Ohio’s definition of a product that can be defective in design
    or formulation.      As a result, genuine issues of material fact remain regarding
    whether Mr. Robinson meets the Ohio statute’s requirement that Ms. Robinson
    prove that Calidria was defective in design or formulation. However, as to the
    proximate cause element of Ms. Robinson’s strict liability claim, Ms. Robinson has
    not identified evidence of record supporting an inference regarding Mr. Robinson’s
    likely exposure to Calidria. For these reasons and those that follow, UCC’s motion
    for summary judgment must therefore be GRANTED.
    2
    Facts of Record
    The facts cited herein are those of record, viewed in the light most favorable
    to Ms. Robinson as the non-moving party.           From 1963 to 1985, UCC mined and
    milled a unique short-fiber variety of asbestos called Calidria. It manufactured two
    different lines of Calidria; UCC designated the product line relevant to this case as
    SG-210. It sold SG-210 in pellet form to third-party manufacturers who then
    incorporated Calidria into consumer products. Those intermediaries in turn sold
    those products to consumer end-users.
    When marketing Calidria, UCC advertised that:
    Calidria asbestos is produced by a proprietary manufacturing process
    that yields unusually high fiber content and more complete fiber
    liberation from the natural bundles. As a result, Calidria asbestos goes
    up to twice as far, pound for pound, as commercial grades of asbestos
    containing large amounts of other filler materials that have no specific
    desirable effect … .
    Evidence of record supports a reasonable inference that UCC’s milling process
    altered the raw asbestos from its original form. It also supports that UCC separately
    marketed its Calidria claiming that it contained only one-half the amount of asbestos
    as compared to typical bulk asbestos.
    UCC sold this SG-210 line of Calidria to Georgia-Pacific. Relevant to this
    case, UCC distributed Calidria to Georgia-Pacific’s Chicago facility from 1970 to
    1977. Georgia-Pacific, in turn, included Calidria in some of the joint compounds it
    manufactured there. From its Chicago facility, Georgia-Pacific distributed these
    joint compounds to consumers in Ohio.            Between 1971 and 1982, Mr. Robinson
    used Georgia-Pacific’s joint compounds on at least ten occasions. Mr. Robinson
    purchased and used these Georgia-Pacific joint compounds in Ohio. He later died
    of lung cancer in late 2016 or early 2017.
    3
    Georgia-Pacific used asbestos in all of its Ready-Mix products from 1965 to
    1977.1 Mr. Robinson used Ready-mix repeatedly during the time of his alleged
    exposure. Included within the summary judgment record are formula cards for
    various Georgia-Pacific compounds. One formula card demonstrates SG-210’s
    inclusion in joint compounds that Georgia-Pacific manufactured at its Chicago
    facility. Other formula cards in the record support that manufacturers other than
    UCC supplied asbestos for the Chicago manufactured compounds.
    Prior to Mr. Robinson’s alleged exposure, internal Georgia-Pacific documents
    demonstrate that its representatives attended Gypsum Association Safety Committee
    meetings as early as September 1966.          The Committee discussed the dangers of
    asbestos at those meetings. In June 1970, Georgia-Pacific’s Safety Supervisor sent
    a letter to the same Committee. That 1970 letter referenced the need for someone to
    be the “whipping boy” to blame for asbestos dangers. In that letter, Georgia-
    Pacific’s safety officer suggested placing “the entire blame . . . on the contractor for
    not insisting on respirators and dust masks.” In addition, other internal Georgia-
    Pacific documents demonstrate that Georgia-Pacific had knowledge of asbestos
    related risks faced by their employees when they handled their own compounds.
    Finally, and most tellingly, in November 1972, a Georgia-Pacific interdepartmental
    communication, “Joint Systems - Status Report,” provided the following:
    [c]onsiderable concern has recently been expressed by various interests
    on the use of asbestos in joint systems. It is therefore proper that you
    should be aware of what is being done to eliminate this raw material
    from our joint system product line. After considerable work, what
    appears to be a suitable replacement for asbestos has now been found.
    . . . If this proves successful it is further hoped that some asbestos-free
    joint compound . . . will be available, on a very limited basis, within the
    first half of next year. 2
    1
    Ex. I, Pl.’s SJ Resp. at 78.
    2
    Ex. H, Def.’s SJ Motion at 13.
    4
    In arguing there is a factual issue regarding Georgia-Pacific’s sophistication,
    Ms. Robinson relies upon a single UCC call report. That report references a call
    between a Georgia-Pacific plant manager and a UCC representative in 1975
    discussing what to advise contractors about sanding techniques to minimize
    exposure.3 Specifically, the log references a UCC employee’s advice to a Georgia-
    Pacific plant manager to tell contractors to wet sponge joint compounds to lessen
    airborne dust.
    Affiant John Myers, an employee at UCC from 1951 to 1985, attested to his
    personal involvement in warning Georgia-Pacific about the dangers of asbestos. He
    spoke at a number of seminars about those dangers. Present at the seminars were
    UCC’s Calidria customers and potential customers. Furthermore, in 1968, UCC
    began placing asbestos warnings on their bags of Calidria. By 1972, UCC changed
    the structure of its warnings to comply with then promulgated OSHA standards. At
    that point, on each bag of Calidria, UCC included the following:
    CAUTION
    Contains Asbestos Fibers
    Avoid Creating Dust
    Breathing Dust May Cause
    Serious Bodily Harm
    Furthermore, beginning in 1968, UCC began sending toxicology reports to Georgia-
    Pacific. Those reports specifically discussed the risk of asbestosis, lung cancer, and
    mesothelioma. UCC revised its reports, explaining those risks, in 1969, 1970, and
    1972.
    3
    Ex. L, Pl.’s SJ Resp.
    5
    Standard
    Summary judgment is appropriate only if there is no genuine issue of material
    fact and the movant is entitled to judgment as a matter of law. 4 When deciding a
    summary judgment motion, the Court must view the evidence in the light most
    favorable to the non-moving party. 5 The burden of proof is initially on the moving
    party to demonstrate that no genuine issues of material fact are present.6 In this
    regard, a “moving defendant always has the burden of producing evidence of
    necessary certitude negating the plaintiff’s claim.” 7
    If the movant meets his or her initial burden, then the burden shifts to the non-
    moving party to demonstrate the existence of material issues of fact. 8 The non-
    movant's evidence of material facts must be sufficient to withstand a motion for
    judgment as a matter of law and sufficient to support the verdict of a reasonable
    jury.9
    No genuine material issues of fact remain regarding the applicability of
    the bulk supplier defense.
    In the Court’s view, duty is the threshold issue in any negligence claim. It
    therefore first examines whether UCC had the duty to warn Mr. Robinson about
    Calidria’s dangers. Ohio substantive law applies to the case at hand. The parties
    agree that there is a bulk supplier defense under Ohio law, but dispute its elements.
    That defense permits a supplier of bulk products to discharge its duty to warn end-
    4
    Super. Ct. Civ. R. 56(c); Moore v. Sizemore, 
    405 A.2d 679
    , 680 (Del. 1979); In re Asbestos
    Litigation, 
    2007 WL 2410879
    , at *1 (Del. Super. Aug 27, 2007).
    5
    Brozaka v. Olson, 
    668 A.2d 1355
    , 1364 (Del. 1995).
    6
    Super. Ct. Civ. R. 56(e); 
    Moore, 405 A.2d at 680
    .
    7
    Ebersole v. Lowengrub, 
    180 A.2d 467
    , 469--470 (Del. 1962).
    8
    
    Id. at 681
    (citing Hurtt v. Goleburn, 
    330 A.2d 134
    (Del. 1974)).
    9
    Lum v. Anderson, 
    2004 WL 772074
    , at *2 (Del. Super. Mar. 10, 2004).
    6
    users about a product’s hazards based upon the supplier’s reasonable reliance upon
    an intermediary to do so.10 Under this doctrine, “a manufacturer can discharge its
    duty to warn by providing the necessary information to an intermediary upon whom
    it can reasonably rely to communicate the information to the ultimate user of the
    product.”11
    UCC and Ms. Robinson argue contrary applications of Ohio’s bulk supplier
    defense based upon the facts of record. If the defense ultimately applies, UCC had
    no duty to warn end-users such as Mr. Robinson regarding the dangers of Calidria.
    Absent application of the defense, UCC would have had the duty to reasonably warn
    Mr. Robinson about Calidria’s dangers.
    At the outset, Ms. Robinson argues that the traditional requirements for the
    defense apply. Namely, she argues UCC would have been relieved of its duty to
    warn Mr. Robinson only if Georgia-Pacific (1) was a sophisticated bulk purchaser,
    (2) if UCC gave Georgia-Pacific an adequate warning, and (3) UCC reasonably
    relied upon Georgia-Pacific to warn its customers. UCC counters that while there is
    no issue of material fact regarding the sufficiency of its warnings to Georgia-Pacific,
    Ohio law requires only two things. Namely, UCC argues that Georgia-Pacific must
    have only been adequately informed about the dangers of bulk asbestos and must
    have had the ability to warn the ultimate consumer.
    In advocating the more limited elements of the defense under Ohio law, UCC
    relies primarily upon a federal case from the Northern District of Ohio, Midwest
    Specialties v. Crown Indus. Products Co.12 Namely, the Midwest decision holds that
    “[a] manufacturer does not act unreasonably by failing to warn intermediate
    purchasers of dangers of which the intermediate purchasers are already
    10
    Midwest Specialties, Inc. v. Crown Indus. Products Co., 
    940 F. Supp. 1160
    , 1165 (N.D. Ohio
    1996).
    11
    
    Id. 12 Id.
                                                   7
    knowledgeable.” 13 In doing so, that court reasoned that warnings to a sophisticated
    intermediary would serve no purpose if the intermediary already appreciated the
    danger.14 According to that court, unless there is a genuine issue of material fact
    regarding the intermediary’s failure to appreciate the danger, the bulk supplier had
    no duty to warn the end-user. In such a case, a bulk supplier’s reliance upon the
    intermediary was automatically reasonable.15
    Ms. Robinson counters UCC’s arguments regarding the limited elements of
    the doctrine by relying upon the Ohio appeals court decision, Roberts v. George V.
    Hamilton, Inc.16 She emphasizes that case’s holding that requires the trier of fact to
    evaluate the reasonableness of the bulk supplier’s reliance on the intermediary.
    Namely, she argues that (1) reasonable reliance is almost always a factual issue, and
    that (2) based on the summary judgment record, UCC did not meet its initial burden
    by demonstrating that UCC’s reliance upon Georgia-Pacific was reasonable. Here,
    the Court need not resolve the dispute regarding Ohio’s elements for the defense.
    There are no genuine issues of material fact regarding the expanded elements that
    Ms. Robinson advocates.
    With regard to the Roberts case, the plaintiff died from mesothelioma
    allegedly caused by defendant’s asbestos-containing insulation. 17 There, the court
    declined to grant summary judgment in favor of the defendant bulk supplier. In
    doing so, it relied upon Comment n of the Restatement (Second) of Torts § 388
    (“Section 388”).18 From that Comment, the court required the trier of fact to weigh
    the following factors:
    the dangers associated with the product, the purpose of the product, the
    form of warning given if any, the reliability of the purchaser of a
    13
    
    Id. 14 Id.
    at 1165--1166.
    15
    
    Id. 16 2000
    WL 875324 (Ct. App. Ohio, Jun. 30, 2000).
    17
    Roberts, 
    2000 WL 875324
    at *1.
    18
    
    Id. at *4.
                                                 8
    conduit, the magnitude of the risk, and the burden imposed on the
    supplier if it must warn all of the users. 19
    Under the facts of that case, the Ohio appeals court found that the facts of record
    precluded summary judgment. 20
    Roberts, however, is distinguishable from the present case. When examining
    the issue of whether the bulk supplier reasonably relied upon the intermediary, the
    evidence of record in Roberts included evidence that (1) there was no warning on
    the asbestos insulation’s packaging, and (2) it did “not appear to be disputed that the
    actual users were unaware of the danger of asbestos exposure.” 21 The Roberts
    decision also included the court’s application of the doctrine in a case where the end-
    users were the intermediary’s employees.
    In the case at hand, the record demonstrates numerous instances where UCC
    warned Georgia-Pacific with toxicology reports, brochures, and prominent warnings
    on UCC’s bags. The Roberts decision referenced no such warnings. Furthermore,
    in this case, Georgia-Pacific included Calidria as a mere component in joint
    compounds that it sold to end-users. There was no means for UCC to warn an end-
    user, such as Mr. Robinson, about asbestos. This is in direct contrast to the situation
    presented in the Roberts decision where the plaintiff was an employee of the
    intermediary that had purchased the insulation. When examining Comment n’s
    factors against the evidence of record in this case, no reasonable jury could find that
    UCC unreasonably relied upon Georgia-Pacific to warn end-users.
    Other decisions applying Ohio law have applied the bulk supplier defense at
    the summary judgment stage. These decisions applied Comment n to Section 388
    and entered summary judgment nevertheless. For instance, the Sixth Circuit Court
    19
    
    Id. 20 Id.
    at *5.
    21
    
    Id. at *4.
                                               9
    of Appeals granted summary judgment in the Adams v. Union Carbide
    Corporation22 case. There, a former GMC employee sued UCC for failure to
    adequately warn him of the dangers of one of UCC’s chemicals. UCC sold the
    chemical to GMC for use in motor vehicle assemblies. In applying the reasonable
    reliance standard as outlined in Comment n to Section 388, that court held UCC’s
    duty as the supplier to be discharged as a matter of law. That court found that UCC
    reasonably relied upon GMC to convey the information to the ultimate users, GMC’s
    employees.23 In doing so, the court held that:
    [the] fact that GMC repeatedly updated its information about [the
    chemical] from Union Carbide, coupled with the fact that GMC itself
    had a duty to its employees to provide them with a safe place to work,
    supports the inescapable conclusion that it was reasonable for Union
    Carbide to rely upon GMC to convey the information about the
    hazardous propensities of [the chemical] to its employees within the
    context of [C]omment n of the restatement.24
    Similarly, in Ditto v Monsanto,25 when applying Ohio law, the federal
    Northern District of Ohio examined a case of leukemia allegedly caused by exposure
    to Monsanto’s chemicals placed by intermediaries into transformers.             There,
    Monsanto moved for summary judgment raising the bulk supplier defense. 26
    Echoing the holding in Adams, the district court found that Monsanto had no duty
    under Ohio law to warn the plaintiff directly where Monsanto supplied chemicals to
    electrical equipment manufacturers who in turn sold the equipment to consumers.27
    As in the case at hand, that court held on summary judgment that Monsanto had no
    ability to place a warning on the product, no way to identify who purchased the
    22
    
    737 F.2d 1453
    (6th Cir. 1984).
    23
    
    Id. at 1457.
    24
    
    Id. 25 867
    F.Supp 585 (N.D. Ohio 1993).
    26
    
    Id. at 591.
    27
    
    Id. at 593.
                                             10
    electrical equipment containing the product, and no way to know who worked with
    the product. 28
    Here, the evidence of record demonstrates that there is no issue of material
    fact regarding Georgia-Pacific’s status as a sophisticated intermediary. By the mid-
    1960s, Georgia-Pacific was a large, publicly-traded company and one of the leading
    manufacturers of drywall and joint-compound products. Georgia-Pacific knew of
    the dangers of asbestos in the mid-1960s. By June 1970, it observed the close
    connection between lung-disease and its own asbestos workers. Later in June 1970,
    it even suggested blaming the contractors as the responsible parties because the
    contractors were not requiring their employees to use respirators and dust masks.
    Continuing into the early 1970s, Georgia-Pacific issued mandatory respiratory
    requirements for its employees that handled asbestos. In 1972, Georgia-Pacific
    issued a memorandum stating that it was phasing out all asbestos in its compounds.
    No reasonable jury could conclude based on the evidence of record that Georgia-
    Pacific failed to appreciate Calidria’s dangers.
    Of the evidence of record, balanced against this is only a call log referencing
    a 1975 call between a UCC employee and a plant manager of an unidentified
    Georgia-Pacific plant. Such evidence does not generate a triable issue of fact
    regarding Georgia-Pacific’s knowledge of the dangers of asbestos or regarding
    UCC’s reliance on Georgia-Pacific. Rather, it merely evidences a discussion with a
    plant manager at a Georgia-Pacific plant about wet sponging the compound to reduce
    dust.       Given UCC’s employees’ participation in providing warnings and data to
    Georgia-Pacific for years prior to this single call, the call log raises no genuine issue
    of material fact regarding UCC’s reliance upon Georgia-Pacific to reasonably warn
    Mr. Robinson. Looming large in the Court’s summary judgment analysis is the
    undisputed reality that UCC had no ability to warn the end-users in this case.
    28
    
    Id. 11 Finally,
    apart from Georgia-Pacific’s sophistication and UCC’s reasonable
    reliance, there is no genuine dispute of material fact regarding the adequacy of
    UCC’s warnings to Georgia-Pacific. Each bag of Calidria contained a warning
    printed on its exterior. In support of its motion, UCC provided an employee’s
    affidavit who attested that he directly warned Georgia-Pacific about Calidria’s
    dangers. UCC also regularly sent MSDS sheets and toxicology reports to Georgia-
    Pacific that addressed Calidria’s dangers.            Ms. Robinson proffers no evidence
    regarding the inadequacies of these warnings.
    In summary, when considering the evidence of record with the appropriate
    deference, no reasonable jury could find for Ms. Robinson on this issue. Namely,
    no jury could reasonably find other than that Georgia-Pacific was (1) fully
    knowledgeable about the dangers of asbestos and was thus sophisticated, (2) UCC
    gave Georgia-Pacific adequate warnings regarding the dangers of Calidria, and (3)
    UCC reasonably relied upon Georgia-Pacific to warn Mr. Robinson. Accordingly,
    summary judgment regarding Ms. Robinson’s duty to warn claim must be
    GRANTED.
    Material issues of fact remain regarding whether the sale of Calidria falls
    within Ohio’s definition of a strict liability claim.
    In a footnote to UCC’s motion for summary judgment, UCC argued that Ms.
    Robinson is unable to sustain a defective design claim against them, because as
    provided in The Restatement (Third) of Torts, a raw material cannot be defectively
    designed. 29 Ms. Robinson did not address UCC’s argument in her written response;
    29
    See Restatement (Third) of Torts: Product Liability § 5, cmt. c (1998) (providing that
    “[r]egarding the seller's exposure to liability for defective design, a basic raw material such as
    sand, gravel, or kerosene cannot be defectively designed. Inappropriate decisions regarding the
    use of such materials are not attributable to the supplier of the raw materials but rather to the
    fabricator that puts them to improper use. The manufacturer of the integrated product has a
    significant comparative advantage regarding selection of materials to be used. Accordingly, raw-
    12
    in fairness, when UCC sought summary judgment regarding one of Ms. Robinson’s
    two claims, it should not have raised it in a footnote.
    At oral argument, Ms. Robinson requested the opportunity to respond. The
    Court permitted supplemental briefing regarding Ms. Robinson’s strict liability
    claim. In this decision, the Court has considered the supplemental arguments and
    the evidence of record cited by the parties. Again, all referenced facts are those
    viewed in the light most favorable to Ms. Robinson.
    Both parties agree Ohio statutes control Ohio strict liability claims. In this
    regard, Ohio’s Product Liability Claims Act (hereinafter “the Act”) “abrogate[s] all
    common law product liability claims and causes of action.”30 The Act first outlines
    product liability claims in general. It then includes specific sections providing for
    strict liability in certain circumstances.31
    The first element of a strict liability claim under Ohio law requires a finder of
    fact to determine whether a product is defective in design or formulation. UCC
    argues that Calidria is raw asbestos and therefore cannot be defectively designed.
    UCC also emphasizes three prior Superior Court decisions where the Superior Court
    held that Calidria could not be designed because it is a bulk product. Third, UCC
    emphasizes two provisions in the Act that it alleges removes a bulk product such as
    Calidria from the provisions of Ohio’s strict liability statute.
    Ms. Robinson counters that a factual issue remains regarding whether asbestos
    fits within the Ohio statutory definition of a product that is “defective in design or
    formulation.” She also emphasizes Ohio case law that recognizes the highly factual
    nature of this issue.
    materials sellers are not subject to liability for harm caused by defective design of the end-product.
    The same considerations apply to failure-to-warn claims against sellers of raw materials”).
    30
    ORC § 2307.71 (B).
    31
    See ORC § 2307.75. Throughout this decision, the Court will alternatively refer to the instant
    claim both as a “defective design or formulation” claim and as one based upon strict liability.
    13
    Since both parties agree that Ohio statutory law controls this issue, the Court
    first turns to the Act’s definitions and provisions. The prior Superior Court decisions
    referenced by UCC do not reference or apply this Act’s provisions. Accordingly,
    the Court does not rely upon them.                  Rather, it addresses Ohio’s statutory
    requirements for this claim.
    The threshold inquiry in the analysis is whether UCC’s sale of Calidria could
    be the subject of a “product liability claim.” At the outset, the definition of “product”
    in the Ohio statute expressly includes “raw material.” 32            Furthermore, a “product
    liability claim” includes, inter alia, a claim arising from the “formulation production
    . . . or marketing” of such a product. 33 Here, Ms. Robinson, as the non-movant, is
    entitled to an inference based on the evidence of record that UCC’s processes
    included the formulation, production, or marketing of Calidria.34
    Furthermore, the Act defines “manufacturer” broadly to include any “person
    engaged in a business to . . . produce . . . a product.”35 There is no dispute on the
    record that UCC fits within that definition.          Given these general product liability
    provisions and definitions, the Court next turns to the more specific provisions
    applicable to Ohio’s strict liability claims.         In short, a manufacturer is subject to
    strict liability if:
    (1) [t]he manufacturer’s product . . . was defective in manufacture or
    construction [or] in design or formulation;
    (2) [a] defective aspect of the manufacturer’s product . . . was a
    proximate cause of harm . . .; [and]
    (3) [t]he manufacturer designed [or] formulated the actual product that
    was the cause of harm . . . .36
    32
    ORC § 2307.71 (A)(12)(a).
    33
    ORC § 2307.71 (A)(13)(a).
    34
    See ORC § 2307.71 (A)(13)(a) (providing further limitations to the definition of a “product” for
    purposes of a “product liability claim”).
    35
    ORC § 2307.71 (9).
    36
    ORC § 2307.73 (A).
    14
    After providing for this type of claim, the Act then includes a separate section
    that addresses specific aspects of Ohio strict liability. Namely, Section 2307.75(A)
    sets limits regarding what type of products fall within strict liability claims. Section
    2307.75 (A) provides that:
    [s]ubject to divisions (D), (E), and (F) of this section, a product is
    defective in design or formulation if, at the time it left the control of its
    manufacturer, the foreseeable risks associated with its design or
    formulation as determined pursuant to division (B) of this section
    exceeded the benefits associated with that design or formulation as
    determined pursuant to division (C) of this section. 37
    UCC focuses primarily on the term “design” in its argument. Even if the
    Court were to accept UCC’s argument that Calidria, as a matter of law, is not
    designed, Section 2307.75 (A) further provides that if Calidria qualifies as a
    “formulation,” marketing Calidria is actionable. Alone, UCC’s marketing materials
    advertising Calidria, if accepted by the trier of fact, establish that Calidria, as altered
    asbestos, constitutes a formulation. Evidence of record further supports that UCC
    marketed its product as part of a “proprietary manufacturing process that yields
    unusually high fiber content and more complete fiber liberation from the natural
    bundles.”      Moreover, apart from the factual issue regarding whether Calidria is a
    “formulation,” an admission from UCC to this effect, separately generates a triable
    issue of fact regarding whether Calidria is “designed.”
    UCC also argues that two separate divisions in this section preclude Ms.
    Robinson’s strict liability claim.         Namely, Section 2307.75(A) provides that
    defective design and formulation claims are “subject to divisions … (E) and (F)” of
    that section. 38
    First, division (E) of Section 2307.75 provides that:
    37
    ORC § 2307.75(A) (emphasis added).
    38
    ORC § 2307.75(A).
    15
    [a] product is not defective in design or formulation if the harm for
    which the claimant seeks to recover compensatory damages was caused
    by an inherent characteristic of the product which is a generic aspect of
    the product that cannot be eliminated without substantially
    compromising the product's usefulness or desirability and which is
    recognized by the ordinary person with the ordinary knowledge
    common to the community.39
    UCC argues that Calidria is exempt from a claim for strict liability under Ohio
    law because the “inherent characteristic of the product” cannot be altered without
    compromising the product’s usefulness.           This argument ignores the second
    requirement in that division. Namely, the division also requires, before exempting
    a product, that “an ordinary person with ordinary knowledge common to the
    community” must recognize the danger of the product. UCC identifies no facts of
    record supporting that an ordinary consumer, such as Mr. Robinson, possessed
    adequate knowledge regarding Calidria’s dangers.
    Second, division (F) of the Section 2307.75 next provides that:
    [a] product is not defective in design or formulation if, at the time the
    product left the control of its manufacturer, a practical and technically
    feasible alternative design or formulation was not available that would
    have prevented the harm … without substantially impairing the
    usefulness or intended purpose of the product.40
    Here, UCC identifies no evidence of record supporting what is in essence an
    affirmative defense. Furthermore, the applicability of this division is called into
    question by UCC’s own advertisements. These include admissions that it produced
    Calidria pursuant to a “proprietary manufacturing process.” Where UCC advertised
    that it employed a proprietary process in producing Calidria, a trier of fact can
    permissibly infer that UCC considered alternatives to that process. Accordingly, a
    39
    ORC § 2307.75(E) (emphasis added).
    40
    ORC § 2307.75(F) (emphasis added).
    16
    factual dispute remains regarding whether division (F) to Section 2307.75 exempts
    UCC from ultimate liability.
    Apart from rote statutory analysis, Ohio state case law also strongly supports
    denying summary judgment on this issue. Here, Ms. Robinson correctly cites Ohio
    authority providing for two relevant avenues for a plaintiff to establish strict liability
    in cases such as this. Most helpful is an Ohio Supreme Court decision. Namely, in
    Perkins v. Wilkinson Sword, Inc.,41 the Ohio Supreme Court recognized when
    applying the provisions discussed above that:
    a product is defective in design or formulation if either of the following
    applies:
    (1) [w]hen it left control of its manufacturer, the foreseeable risks
    associated with its design or formulation . . . exceeded the benefits
    associated with the design or formulation . . ; [or]
    (2) [i]t is more dangerous than an ordinary consumer would
    expect when used in an intended or reasonably foreseeable
    manner.
    In the Perkins decision, the Ohio Supreme Court answered a certified question
    from the United States Court of Appeals for the Sixth Circuit. 42 When doing so, it
    rejected prior authority that the risk/utility test portion of subdivision (E) to Section
    2307.75 applies “only when . . . the product could be made safer through an
    alternative design and not when the product is by itself dangerous.” 43 Furthermore,
    the Ohio Supreme Court rejected the argument that division (E)’s risk/utility test
    does not apply when a dangerous product is functioning properly. 44 When applying
    the Perkins decision’s reasoning to the facts of this case, UCC has not met its initial
    burden on summary judgment to negate Ms. Robinson’s claim under either the
    41
    
    700 N.E.2d 1247
    , 1249 (Ohio 1998).
    42
    
    Id. at 1247.
    43
    
    Id. at 1249.
    44
    
    Id. at 1249-1250.
                                               17
    risk/utility test provided in division (F), or the appreciable danger tests provided in
    division (E).
    Notwithstanding that Calidria may be defective in design or
    formulation, Ms. Robinson has not demonstrated a genuine issue of material
    fact regarding product identification.
    The disposition of this portion of UCC’s motion turns on the second element
    of an Ohio strict liability claim. Namely, an Ohio defective design and formulation
    claim requires a plaintiff to demonstrate proximate cause. 45 As a prerequisite to
    proving proximate cause in any product liability case, a plaintiff must prove more
    likely than not that it was the defendant’s product that caused the harm. 46 If there is
    not at least a probability of exposure to a defendant’s product, that product could not
    have proximately caused a plaintiff’s injury.
    The evidence of record regarding product identification is mixed. Both parties
    emphasize formula cards referencing SG-210 as a component in various Georgia-
    Pacific compounds. In this regard, UCC has met its initial burden on summary
    judgment by identifying formula cards for Georgia-Pacific’s relevant products that
    do not include Calidria. UCC also identifies evidence of record supporting that UCC
    was a minor supplier of asbestos during the times of Mr. Robinson’s use of the
    products.
    On the other hand, Ms. Robinson references one formula card that supports
    that Georgia-Pacific included Calidria in joint compounds that it manufactured in
    Chicago. Ms. Robinson also provides a number of formula cards that reference
    45
    ORC § 2307.73.
    46
    Fogle v. Cessna, 
    1992 WL 10272
    , at *4 (Ohio Ct. App. Jan. 16, 1992). See also Richards v.
    Copes-Vulcan, Inc., 
    2019 WL 3282056
    , at *4 (Del. Jul. 22, 2019) (discussing ORC § 2307.96
    and Ohio’s statutory requirement of substantial factor analysis regarding proximate cause). The
    Court need not address the substantial factor test because there is no issue of fact regarding Mr.
    Robinson’s probable exposure to Calidria.
    18
    Calidria in the recipe used at Georgia-Pacific’s Akron, New York plant. Ms.
    Robinson argues that (1) these formula cards, (2) an admission in UCC’s briefing
    that after 1974, Georgia-Pacific increased its usage of Calidria, and (3) that all
    Georgia-Pacific’s joint compounds during that period contained asbestos, permit a
    reasonable inference of Mr. Robinson’s exposure to Calidria.
    The burden of proof at trial is on the plaintiff to establish proximate cause by
    a preponderance of the evidence. At this stage of the proceedings, because UCC has
    met its initial burden on summary judgment, Ms. Robinson must demonstrate facts
    of record that would permit a reasonable jury to infer product identification by a
    preponderance of the evidence. While proximate cause is generally an issue of
    fact,47 a jury cannot be left to speculate regarding whether Mr. Robinson was
    exposed to a UCC product. 48 Both counsels’ arguments referencing formula cards,
    their meanings, and the extent to which they may or may not cover the universe of
    products manufactured at the Chicago plant, are merely argument. Such argument
    does not independently justify or defeat a required inference, absent evidence of
    record.
    At the outset, the Court acknowledges that some prior Superior Court cases
    have seemingly altered the burden of proof regarding product identification.
    Namely, some of these decisions, oral and written, have applied a blanket rule
    requiring summary judgment if two or more bulk suppliers supplied asbestos to an
    intermediary, absent direct evidence of a plaintiff’s exposure. Some other decisions
    have properly applied traditional tort law concepts, but due to their brevity, have
    been repeatedly cited as providing for non-traditional tort law principles.
    For instance, in Sturgill v. 3M Company,49 this Court granted summary
    judgment in favor of Union Carbide when finding that the plaintiff in that case could
    47
    Fogle, 
    1992 WL 10272
    , at *4.
    48
    
    Id. 49 2017
    WL 6343519, at *1 (Del. Super. Dec. 11, 2017).
    19
    show no more than that UCC was one of multiple suppliers of asbestos to the
    intermediary.50 Likewise, in Aveni v. UCC,51 the Superior Court granted summary
    judgment by finding that while the evidence of record demonstrated that UCC
    supplied Calidria to the intermediary joint compound manufacturer, UCC was not
    the intermediary’s sole supplier.52 As a result, with no further analysis, the Court in
    Aveni held that it would require “pure speculation, that the product [used by the
    plaintiff] contained asbestos and the asbestos was provided by Union Carbide.” 53
    Most recently, in Rowland v. American Biltrite, Inc.,54 the Superior Court granted
    summary judgment based on product identification. There, UCC, Georgia-Pacific,
    and Ohio law were all involved. While the Plaintiff in that case did not contest
    summary judgment regarding defective design or formulation, many of the same
    formula cards and arguments raised in that case were at issue in this case.
    These written decisions and a significant number of Superior Court oral
    summary judgment decisions echo a principle set forth in Nutt v. A.C. & S. Co., Inc.,
    55
    which causes some of the confusion. No Delaware Supreme Court decision, to
    this Court’s knowledge, has approved applying Nutt’s reasoning rejecting market
    share liability in the way UCC requests and in the manner that many Superior Court
    decisions have applied it. In this Court’s view, Nutt’s holding rejecting market-share
    liability has improperly bled into what should be a traditional proximate cause
    analysis.
    In Nutt, the Superior Court correctly held that absent legislation adopted by
    the General Assembly, Delaware law does not provide for alternative liability such
    50
    
    Id. at *3.
    51
    
    2017 WL 5594055
    , at *1 (Del. Super. Nov. 8, 2017).
    52
    
    Id. 53 Id.
    at *2.
    54
    
    2019 WL 1787451
    , at *1 (Del. Super. Apr. 24, 2019).
    55
    
    517 A.2d 690
    (Del. Super. 1986).
    20
    as market-share liability.56 Ohio has also not adopted market-share liability as a
    means for bypassing traditional proximate cause requirements.57                  In Nutt, the
    Superior Court granted summary judgment based on product nexus because (1) no
    records existed showing shipments of the defendant’s asbestos to the relevant plant,
    and (2) there were other suppliers.58         The plaintiff in that case sought to apply
    market-share liability. At the outset, that situation is distinguishable from the case
    at hand. Here, there is evidence of record demonstrating that UCC shipped Calidria
    to the Chicago plant for use in Georgia-Pacific’s products that it sold in Ohio.
    Market-share liability is a concept wherein a plaintiff seeks to impose
    collective liability on a product’s manufacturer in the absence of any evidence
    identifying the manufacturer of the product causing the harm. This constitutes
    alternative liability because the identity of the manufacturer cannot be determined
    and the plaintiff is “unable to identify any of the specific manufacturers responsible
    for the harm.”59 Absent any evidence of product identification, that concept permits
    a finding of exposure based upon only upon an asbestos supplier’s overall share of
    the market.
    In some Superior Court cases decided since Nutt, the Superior Court has
    imposed an impossible and inappropriate burden on the plaintiff.                 These cases
    require a plaintiff to provide evidence justifying an inference of certainty of exposure
    when two or more suppliers provided asbestos to the intermediary. Such a blanket
    requirement does not flow from traditional concepts of tort law. Furthermore, such
    an approach ignores that the standard of proof is to a preponderance of the evidence
    56
    
    Id. at 694.
    57
    See Sutowski v. Eli Lilly & Co., 
    696 N.E.2d 187
    , 188 (Ohio 1998) (holding that “[i]n Ohio,
    market-share liability is not an available theory of recovery in a products liability action”).
    58
    
    Nutt, 517 A.2d at 693
    .
    59
    Richard E. Kaye, “Concert of Activity,” “Alternate Liability,” “Enterprise Liability,” or
    Similar Theory as Basis for Imposing Liability Upon One or More Manufacturers of Defective
    Uniform Product, in Absence of Identification of Manufacturer of Precise Unit or Batch Causing
    Injury, 
    63 A.L.R. 5th 195
    , § 2[b] (1998).
    21
    and that a plaintiff may meet his or her burden of proof by circumstantial evidence
    alone. In fact, circumstantial evidence may establish the entire basis for recovery
    when a plaintiff is unable to specifically identify the manufacturers’ asbestos
    products as the one to which he or she was directly exposed. 60 Direct, circumstantial,
    or statistical evidence suffices to generate an issue of material fact regarding product
    identification if the evidence provides at least a reasonable inference of a greater
    than fifty-percent chance of exposure to the defendant’s product.
    Here, the Court recognizes the appropriate deference due to Ms. Robinson
    regarding the issue of proximate cause.            Nevertheless, she has not identified
    sufficient evidence of record that would justify any reasonable jury in finding for her
    on the issue of product identification. Formula cards, without context, where some
    cards list Calidria as an ingredient and some do not, together with an admission by
    UCC that it increased shipments of Calidria to Georgia-Pacific during the relevant
    period, do not alone meet Ms. Robinson’s duty on summary judgment to
    demonstrate a genuine issue of material fact. Adding in the sole additionally cited
    fact recognizing that Georgia-Pacific may have included asbestos in all of its joint
    compounds during the relevant time does not alter that reality. She identifies no
    further circumstantial evidence, statistical evidence, systems engineering expert
    opinion, or other evidence of record from a Georgia-Pacific representative in support
    of proving Mr. Robinson’s exposure to Calidria.
    On balance, there is no question that evidence of record supports an inference
    that there was a possibility of exposure to UCC’s asbestos. However, Ms. Robinson
    has not stepped forward with evidence supporting a reasonable inference that there
    was a probability of exposure to UCC’s asbestos at any period of time relevant to
    this claim. Under these facts of record, the trier of fact would be forced to speculate
    regarding this material issue of fact. That decision cannot be left to speculation.
    60
    Am. L. Prod. Liab. 3d § 122.35 (2019).
    22
    Conclusion
    For the foregoing reasons, Defendant Union Carbide Corporation’s motion
    for summary judgment must be GRANTED.
    /s/Jeffrey J Clark
    Judge
    23